Related content

Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0

By You Kai-yun   Huang Rong   Ding Pei-rong   Qiu Bo   Zhou Guan-qun   Chang Hui   Xiao Wei-wei   Zeng Zhi-fan   Pan Zhi-zhong   Gao Yuan-hong  

International Journal of Colorectal Disease, Vol. 29, Iss. 4, 2014-04 ,pp. : 529-538

Springer Publishing Company

Access to resources Recommend Favorite

Incidence of Metachronous Distant Metastasis and ypN Classification Influence Patient Survival in Endosonographically Confirmed uT3 Rectal Cancer after Neoadjuvant Therapy and R0 Resection: A Historical Cohort Analysis

By  

Visceral Medicine (formerly: Viszeralmedizin), Vol. 32, Iss. 2, 2016-01 ,pp. : 131-136

Karger

Access to resources Recommend Favorite

Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer

By  

Digestive Surgery, Vol. 32, Iss. 4, 2015-05 ,pp. : 229-237

Karger

Access to resources Recommend Favorite

In vivo lymph node mapping and pattern of metastasis spread in locally advanced mid/low rectal cancer after neoadjuvant chemoradiotherapy

By Farinella E.   Viganò L.   Fava M.   Mineccia M.   Bertolino F.   Capussotti L.  

International Journal of Colorectal Disease, Vol. 28, Iss. 11, 2013-11 ,pp. : 1523-1529

Springer Publishing Company

Access to resources Recommend Favorite

Delayed Surgery for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A Promising Method in Its Infancy

By  

Digestive Surgery, Vol. 29, Iss. 4, 2012-08 ,pp. : 281-286

Karger

Access to resources Recommend Favorite